View Older Stories View More Recent Stories

Jun 15, 2025 10:36PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM
Jun 12, 2025 08:33AM Tempus AI (TEM) Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research
Jun 9, 2025 10:56PM ROSEN, A LEADING LAW FIRM, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM
Jun 8, 2025 10:51PM ROSEN, NATIONALLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM
Jun 6, 2025 09:05PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM
Jun 3, 2025 03:57PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM
Jun 2, 2025 08:47AM TD Cowen Defends Tempus AI Inc (TEM): 'Stock Reaction Looks Overdone'
Jun 2, 2025 08:31AM Tempus AI (TEM) Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers
May 28, 2025 09:13AM Tempus AI (TEM) Mentioned as Short at Spruce Point
May 20, 2025 08:33AM Tempus AI (TEM) Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment
May 14, 2025 08:31AM Tempus AI (TEM) Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline
May 8, 2025 09:24AM Morgan Stanley on Tempus AI Inc (TEM): 'Solid Start to the Year'
May 6, 2025 04:13PM Tempus AI, Inc (TEM) Tops Q1 EPS by 2c
Apr 28, 2025 08:30AM Tempus AI (TEM) Introduces Loop
Apr 23, 2025 08:00AM Tempus AI (TEM) Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology
Apr 21, 2025 06:05AM BTIG Starts Tempus AI Inc (TEM) at Buy
Apr 15, 2025 09:15AM Illumina (ILMN) and Tempus (TEM) partner to drive the future of precision medicine through genomic AI innovation
Mar 11, 2025 05:16PM Tempus AI (TEM) to acquire Deep 6 AI
Feb 25, 2025 09:09AM Stifel Reiterates Hold Rating on Tempus AI Inc (TEM)
Feb 25, 2025 09:06AM Tempus AI (TEM) Files for 4.84M Share Offering by Selling Stockholders
Feb 25, 2025 05:13AM JPMorgan Downgrades Tempus AI Inc (TEM) to Neutral
Feb 24, 2025 04:50PM After-hours movers: Zoom, Hims & Hers Health, Tempus AI, and more
Feb 24, 2025 04:04PM Tempus AI, Inc (TEM) Reports Q4 Loss of $0.18
Feb 24, 2025 10:46AM Tempus AI (TEM) call put ratio 1.6 calls to 1 put into quarter results and outlook
Feb 24, 2025 05:01AM Tempus AI (TEM) call put ratio 1.4 calls to 1 put into quarter results
Feb 21, 2025 11:00AM Tempus AI (TEM) call put ratio 2.3 calls to 1 put into quarter results
Feb 21, 2025 08:33AM Tempus AI (TEM) and Stemline Therapeutics Collaborate to Implement Tempus Next
Feb 21, 2025 06:21AM Tempus AI (TEM) call put ratio 1.9 calls to 1 put into quarter results
Feb 18, 2025 04:50PM Ares Management (ARES) provides Tempus with total debt package of $560 million
Feb 14, 2025 11:02AM Increasing unusual put option volume: GDDY SMMT FITB AUR TXRH VTRS MNST SATS KC TEM TWLO
Feb 13, 2025 10:19AM Increasing unusual call option volume: EWW CRSR CENX BROS IAU TEM
Feb 12, 2025 09:40AM Tempus AI stock downgraded by William Blair after massive rally
Feb 12, 2025 07:15AM William Blair Downgrades Tempus AI Inc (TEM) to Market Perform
Feb 6, 2025 06:03AM Increasing unusual put option volume: FMC EA HBAN TPX ICE EXE TKO BBAI MTCH TEM
Feb 5, 2025 10:18AM Increasing unusual call option volume: DINO BCRX FMC ACB EA VSH TEM GPRO SAN JCI
Feb 5, 2025 07:00AM TD Cowen Reinstates Tempus AI Inc (TEM) at Buy
Feb 3, 2025 10:23AM Tempus AI (TEM) call put ratio 3.1 calls to 1 put into quarter results
Jan 31, 2025 10:42AM Tempus AI (TEM) call put ratio 5.5 calls to 1 put with a focus on July 70 calls into quarter results
Jan 28, 2025 08:02AM Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways (TEM)
Jan 24, 2025 06:15AM Increasing unusual put option volume: EWC EA YOU XLI EDR MLCO BTG HIMX VERU ALK TKO TEM
Jan 21, 2025 11:24AM Tempus AI (TEM) call put ratio 3 calls to 1 put with as share price up 39%
Jan 21, 2025 10:16AM Increasing unusual put option volume: LW FTAI WMB WEN XP FAST CFG RGTI CLMT IYR TEM
Jan 21, 2025 08:33AM Tempus AI (TEM) Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for Patients
Jan 15, 2025 08:32AM Tempus AI (TEM) Announces the National Launch of FDA-Approved xT CDx Test
Jan 14, 2025 07:20AM Tempus AI Inc (TEM) PT Lowered to $52 at Loop Capital
Jan 13, 2025 08:33AM Tempus AI (TEM) Announces xH
Jan 13, 2025 08:02AM Tempus AI (TEM) Announces Preliminary Fourth Quarter and Full Year 2024 Results
Jan 8, 2025 11:59AM Tempus AI (TEM) Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms
Nov 12, 2024 07:56AM Tempus AI Inc (TEM) PT Raised to $70 at Piper Sandler
Nov 11, 2024 03:23AM Stifel Downgrades Tempus AI Inc (TEM) to Hold
View More Recent Stories View Older Stories